LPL Financial’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

LPL Financial’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-33,925	Closed	-$226K	–	4935
2023 Q3	$226K	Sell	33,925 -1,730	-5%	-$14.4K	﹤0.01%	4145
2023 Q2	$323K	Sell	35,655 -51,485	-59%	-$454K	﹤0.01%	3782
2023 Q1	$634K	Buy	87,140 +8,070	+10%	+$59.9K	﹤0.01%	3139
2022 Q4	$576K	Hold	79,070	–	–	﹤0.01%	3120
2022 Q3	$611K	Buy	79,070 +57,160	+261%	+$485K	﹤0.01%	2963
2022 Q2	$149K	Buy	+21,910	New	+$168K	﹤0.01%	4028

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

LPL Financial's PNT Position: Q4 2023 in Review

LPL Financial sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 33,925 shares — an estimated $226K sold.

LPL Financial first reported a position in PNT in Q2 2022 and held it in 6 quarters. The position peaked at $634K in Q1 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

LPL Financial reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
LPL Financial sold 33,925 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $226K.
LPL Financial first reported a position in POINT Biopharma Global Inc. Common Stock in Q2 2022 and held it in 6 quarters.
LPL Financial's POINT Biopharma Global Inc. Common Stock position peaked at $634K in Q1 2023.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on LPL Financial's 13F filing for Q4 2023, filed 14 Feb 2024.